IDEAYA Biosciences
Tracked across 1 events · 9 articles · First seen Jun 08, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
IDEAYA Biosciences, a precision medicine oncology company, announced and priced a public offering of common stock and pre-funded warrants, aiming to raise approximately $300.0 million. The offering includes 5,555,556 shares of common stock at $27.00…
Impact: IDEAYA Biosciences is raising approximately $300.0 million through a public offering of common stock and pre-funded warrants, which will provide capital for its operations and drug development.
Jun 08, 2026 · 9 articles
100
IDEAYA Biosciences announced public offeringIDEAYA Biosciences $300M...
80
IDEAYA Biosciences granted option to purchaseIDEAYA Biosciences $300M...
70
JPMorgan Chase acted as manager IDEAYA BiosciencesIDEAYA Biosciences $300M...
70
Jefferies acted as manager IDEAYA BiosciencesIDEAYA Biosciences $300M...
70
Toronto-Dominion Bank — TD Cowen acted as manager IDEAYA BiosciencesIDEAYA Biosciences $300M...
70
UBS acted as manager IDEAYA BiosciencesIDEAYA Biosciences $300M...
70
Cantor Fitzgerald acted as manager IDEAYA BiosciencesIDEAYA Biosciences $300M...
60
Wedbush Securities acted as lead manager IDEAYA BiosciencesIDEAYA Biosciences $300M...
NEWSDESK
Track IDEAYA Biosciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard